Spin your science into gold: direct to consumer marketing within social media platforms.
We describe the emerging issues related to warnings with respect to pharmaceutical company use of the internet as a vehicle for direct-to-consumer marketing (DTC) and market research. We describe the various techniques pharmaceutical companies have used to exploit this new communications medium which permits two way exchange of information. The Food and Drug Administration (FDA) has not issued any specific regulations to control internet based misbranding. We describe some examples of the FDA's application of historic regulations to pharmaceutical company use of this new medium and suggest.
Department of Family Medicine, Brown University, Warren Alpert School of Medicine, 8 N Main Street, Suite 401, Attleboro, MA, USA. degilman@egilman.com
David
D
Egilman
Nicholas M
NM
Druar
D004345:Drug Industry / Q000941:ethics* / Q000331:legislation & jurisprudence*; D005607:Fraud; D006801:Humans; D040541:Marketing / Q000941:ethics* / Q000331:legislation & jurisprudence*; D061108:Social Media; D057211:Webcasts as Topic